Onasemnogene abeparvovec gene therapy post-nusinersen or risdiplam showed meaningful motor improvements in children with SMA, with a manageable safety profile. The study cohort included older, heavier ...
Forbes contributors publish independent expert analyses and insights. I am a Forbes.com Contributor specializing in geriatric health and women's health articles. ROSTOV-ON-DON, RUSSIA - FEBRUARY 11, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback